1. New antibiotic approved for drug-resistant tuberculosis  The Washington Post
  2. Treatment for extreme drug-resistant tuberculosis wins US government approval  Nature.com
  3. View full coverage on Google News
The drug was developed by a nonprofit group, in what some hope will become an alternative model since drug companies have largely abandoned the unprofitable work.The drug was developed by a nonprofit group, in what some hope will become an alternative model since drug companies have largely abandoned the unprofitable work.

New antibiotic approved for drug-resistant tuberculosis - The Washington Post

The three-drug regimen cures 90% of people who have the deadliest form of the disease. The three-drug regimen cures 90% of people who have the deadliest form of the disease.The three-drug regimen cures 90% of people who have the deadliest form of the disease.

Treatment for extreme drug-resistant tuberculosis wins US government approval

TRENTON, N.J. (AP) — U.S. regulators Wednesday approved a new tuberculosis medicine that shortens and improves treatment for the hardest-to-treat cases, a worsening problem in many poor... TRENTON, N.J. (AP) — U.S. regulators Wednesday approved a new tuberculosis medicine that shortens and improves treatment for the hardest-to-treat cases, a worsening problem in many poor...

Tuberculosis (TB) is classified as an infectious disease that is caused by Mycobacterium tuberculosis that generally infects human lungs. However, it can also affect other body parts or organs. The other three major types of tuberculosis that are found include latent, active, as well as drug-resistant tuberculosis. The symptoms of tuberculosis cannot be identified in …

Tuberculosis Drugs Market - Research Methodology & Rapid Growth Till 2028 | Tribune Updates

Uttar Pradesh, a new drug in UP, a new drug to fight the multi-drug resistant tuberculosis, new anti-TB drug, drug from the union governmentA new drug known as delamanid would be introduced in UP in the third quarter of the year, as per the central guidelines.

New drug | fight multi-drug resistant TB | UP | TheHealthSite.com

“With Netherlands' public investments @TBAlliance has developed a treatment for resistant tuberculosis, this innovation has been made possible by public and private cooperation. Important step in reaching SDG3. @leavingnoonebehind https://t.co/AboiEPhCpT”

Sigrid Kaag on Twitter: "With Netherlands' public investments @TBAlliance has developed a treatment for resistant tuberculosis, this innovation has been made possible by public and private cooperation. Important step in reaching SDG3. @leavingnoonebehind https://t.co/AboiEPhCpT"

“FDA just approved a new treatment for drug-resistant #tuberculosis(TB). As co-chair of the TB Elimination Caucus, I applaud FDA for helping bring new lifesaving treatments to patients. But, we must do more to eliminate TB. Why I intro'd the Comprehensive TB Elimination Act.”

Eliot Engel on Twitter: "FDA just approved a new treatment for drug-resistant #tuberculosis(TB). As co-chair of the TB Elimination Caucus, I applaud FDA for helping bring new lifesaving treatments to patients. But, we must do more to eliminate TB. Why I intro'd the Comprehensive TB Elimination Act."

“The @US_FDA okays new drug that shortens, improves treatment of highly #drug-resistant #tuberculosis as part of 3-pill regimen. It’s the first TB drug developed by a nonprofit group, and just the third new FDA-approved TB drug in over four decades for TB. https://t.co/rEk8ZujUNg”

Linda A. Johnson on Twitter: "The @US_FDA okays new drug that shortens, improves treatment of highly #drug-resistant #tuberculosis as part of 3-pill regimen. It’s the first TB drug developed by a nonprofit group, and just the third new FDA-approved TB drug in over four decades for TB. https://t.co/rEk8ZujUNg… https://t.co/gIV4Vmsk6z"

“Drug resistant TB: ‘groundbreaking’ drug approved by US regulators  https://t.co/2oygpdOxCC via @Telegraph”

Jeremy Farrar on Twitter: "Drug resistant TB: ‘groundbreaking’ drug approved by US regulators  https://t.co/2oygpdOxCC via @Telegraph"